## Note
nid: 1489968286922
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_1::Zanki_Pharmacology, #AK_Step1_v11::#FirstAid::02_Immunology::04_Immunosuppressants::04_Therapeutic_Antibodies, #AK_Step1_v11::#FirstAid::02_Immunology::04_Immunosuppressants::04_Therapeutic_Antibodies::Alemtuzumab, #AK_Step1_v11::#FirstAid::10_Hematology_Oncology::05_Pharm::20_Alemtuzumab, #AK_Step1_v11::#OME_banner::Basic_Science::07_Immunology, #AK_Step1_v11::#Physeo::09_Pharm::17_Hem/Onc_Pharm::Rituximab_Bevacizumab_Alemtuzumab_Cetuximab_Panitumumab_Trastuzmab, #AK_Step1_v11::#Pixorize::01_Immunology::07_Leukemias_&_Lymphomas::04_CLL, #AK_Step1_v11::#SketchyPharm::Immunology-&-Biochemistry-Pharmacology::Immuno-suppressives::General-Immunotherapy, #AK_Step1_v11::^Other::^EXPN, #AK_Step1_v11::^Other::^HighYield::1-HighYield
markdown: false

### Text
<div>
  <div>
    <i><!--anki--></i>
  </div>
  <div>
    <b>Alemtuzumab</b> is primarily used to treat {{c1::<b>Chronic
    Lymphocytic Leukemia</b>}} and <b>{{c2::Multiple
    Sclerosis}}</b>
  </div>
</div>

### Extra
<div><img src="paste-89507118448641.jpg" class="" style=
"width: 600px; min-width: var(--w);"></div>
<div><img src="paste-95554432401409.jpg" class="" style=
"width: 600px; min-width: var(--w);"></div>

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid


### Sketchy


### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href=
  "https://onlinemeded.org/spa/immunology?ref=anki"><img src=
  "_OME_AnkiFlashcards_Topic_3.png"></a>
</div>

### Additional Resources


### One by one

